Anna Michelle Slaydon Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 122 Gazebo Dr, Elon, NC 27244 Phone: 336-317-4007 |
Ms. Carolyn Westbrook Mclamb, M ED, NBCC, NCLPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 115 Oakview Dr, Elon, NC 27244 Phone: 336-584-7560 |
Katie Marie Chrisco, LCMHC ASSOCIATE Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2100 Elon Ct, Elon, NC 27244 Phone: 336-260-3499 |
Mrs. Heather Williams Mcmahon, LCMHC Counselor - Professional Medicare: Medicare Enrolled Practice Location: 108 Elm Crest Ln, Elon, NC 27244 Phone: 919-525-1198 |
News Archive
Despite decades of study, schizophrenia has remained stubbornly difficult to diagnose in its earliest stage - between the appearance of symptoms and the development of the disorder. Now, a new analysis led by researchers at the UNC School of Medicine and the Renaissance Computing Institute identified illogical thoughts as most predictive of schizophrenia risk.
A new study published in The British Medical Journal by researchers including SFU health sciences professor Scott Lear found consuming a high number of refined grains, such as croissants and white bread, is associated with a higher risk of major cardiovascular disease, stroke and death.
SOS Children's Villages, a global organization dedicated to the long-term care and prevention of orphaned and abandoned children, are currently caring for the 33 children who are alleged victims of child trafficking. The Haitian Social Ministry entrusted SOS with the children – who range from three months to 12 years - after Haitian police arrested 10 U.S. citizens attempting to take the children from Haiti to the Dominican Republic on January 29 in a suspected illicit adoption scheme. The suspects did not have official papers confirming the identities of the children, nor did they have official permission to bring the children out of the country.
Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company"), a medical device company focused on infectious disease and dermatology, today provided an update to a previously announced exclusive evaluation and option to license agreement (the "Agreement") with a global, multi-billion dollar healthcare company covering the use of the Company's CeraShield antimicrobial technology for a specific medical device associated with a high incidence of hospital acquired infections.
› Verified 1 days ago